|This Slide: #54 of 83|
Slide #54. Emergent BioSolutions Inc. — Healthcare Protective Products Division from Bracco Diagnostics Inc.
Emergent BioSolutions Inc. (NYSE:EBS)
Healthcare Protective Products Division from Bracco Diagnostics Inc.
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration (FDA) for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
Emergent BioSolutions is a life sciences company focused on providing a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). Co. is focused on products and solutions that address the following five distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). Co. has a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products).
EBS SEC Filing Email Alerts Service
Open the EBS Page at The Online Investor »
Buy (3.14 out of 4)